Scarica l'app Stockscreener
1.94
1.57%
0.03
Dopo l'orario di chiusura:
1.96
0.02
+1.03%
Precedente Chiudi:
$1.91
Aprire:
$1.93
Volume 24 ore:
4,490
Relative Volume:
0.04
Capitalizzazione di mercato:
$76.74M
Reddito:
$63.15M
Utile/perdita netta:
$-40.30M
Rapporto P/E:
-1.1617
EPS:
-1.67
Flusso di cassa netto:
$-44.47M
1 W Prestazione:
-2.51%
1M Prestazione:
+12.14%
6M Prestazione:
-26.79%
1 anno Prestazione:
-58.55%
Intervallo 1D:
$1.93
$1.96
Intervallo di 1 settimana:
$1.5977
$2.1859
Portata 52W:
$0.8645
$4.78
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Confronta TELA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.94 | 75.55M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
TELA Bio Soft-Tissue Tech Showcase: Key Investor Presentation Coming August 13 at Canaccord Conference - Stock Titan
What analysts say about TELA Bio Inc. stockTremendous financial leverage - Autocar Professional
TELA Bio to Announce Q2 2025 Results with Live Webcast and Corporate Update - MyChesCo
What drives TELA Bio Inc. stock priceDynamic profit expansion - jammulinksnews.com
TELA Bio Inc. Stock Analysis and ForecastTremendous growth opportunities - jammulinksnews.com
TELA Bio to Announce Second Quarter 2025 Financial Results - GlobeNewswire
Medical Tech Leader TELA Bio Sets Q2 Earnings Date: Key Financial Results Coming August 11 - Stock Titan
Is TELA Bio Inc. a good long term investmentTriple-digit profit margins - Autocar Professional
Will TELA Bio Inc. stock benefit from AI tech trendsShort Squeeze Radar - Newser
How TELA Bio Inc. stock performs during market volatilityFree Stock Market Group - beatles.ru
Why TELA Bio Inc. stock is on top investor watchlists3x Return Stock Radar - Newser
Further Upside For TELA Bio, Inc. (NASDAQ:TELA) Shares Could Introduce Price Risks After 32% Bounce - simplywall.st
Why TELA Bio Inc. stock attracts strong analyst attentionMarket Timing Advice - Newser
What makes TELA Bio Inc. stock price move sharplyFree Exclusive Stock Market Insights - Newser
TELA Bio (NASDAQ:TELA) Shares Down 5.4% – Here’s What Happened - Defense World
TELA Bio's Growth Crossroads: Can Revenue Momentum Outweigh Persistent Losses? - AInvest
Universal Media Group (OTCMKTS:UMGP) vs. TELA Bio (NASDAQ:TELA) Critical Comparison - Defense World
Wall Street Zen Downgrades TELA Bio (NASDAQ:TELA) to Sell - Defense World
Millennium Management LLC Has $183,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio Launches OviTex Reinforced Tissue Matrix for Hernia Repair in Europe - MSN
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):